U.S. vaccine advisory panel recommends FDA authorize Pfizer COVID-19 shot
The FDA is expected to swiftly authorize Pfizer's COVID-19 vaccine following the recommendation. The vaccine will also need the approval of New York's independent review panel. |!|…